Chelsea Swanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chelsea Swanson has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Latest Publications
- Open Access
- 23 December 2025
- Published by North Carolina Institute of Medicine in North Carolina Medical Journal
- Vol. 86 (4)
Scaling What Works: Evidence-based Prevention, Data, and Collaboration in North Carolina’s Medicaid Transformation
NC Medicaid’s investments in whole-person care and data infrastructure have driven meaningful progress in improving health at lower costs. Amid growing fiscal pressures and upcoming policy reforms, continuing to advance evidence-based prevention, strengthen data infrastructure, and foster multistakeholder collaboration will be needed to drive sustainable, cost-effective, whole-person care transformation.
- 23 December 2025
- Published by North Carolina Institute of Medicine in North Carolina Medical Journal
- Vol. 86 (4)
Open AccessScaling What Works: Evidence-based Prevention, Data, and Collaboration in North Carolina’s Medicaid Transformation
NC Medicaid’s investments in whole-person care and data infrastructure have driven meaningful progress in improving health at lower costs. Amid growing fiscal pressures and upcoming policy reforms, continuing to advance evidence-based prevention, strengthen data infrastructure, and foster multistakeholder collaboration will be needed to drive sustainable, cost-effective, whole-person care transformation.
- Open Access
- 23 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Isolation of Hymenolepis diminuta Cysticercoids for therapeutic use: The need for open-source methodology (Preprint)
BACKGROUND Helminth therapy holds considerable theoretical promise for clinical and public health applications. Unfortunately, clinical trials have often used helminths produced using methods that are both highly variable and insufficiently described in the literature, which may hinder reproducibility and troubleshooting. OBJECTIVE This study aimed to devise a method for purification of helminths that avoids mechanical filtration, which may damage some organisms. In particular, the goal was to devise a method to separate large quantities of cysticercoids of the cestode species Hymenolepis diminuta (HDCs), a process that has not been described previously but that would be necessary before HDCs can be used clinically. METHODS The physical size and behavior of HDCs in solution were assessed and used to create a patented washing device. RESULTS The cross-sectional area of HDCs varied over a 10-fold range, from approximately 0.06 to 0.6 mm2, dependent in large part upon the host. That cross-sectional area correlated in a linear fashion with the steady-state speed of HDCs while falling through solution, which varied over a 5-fold range, from approximately 0.4 mm/s to 2.0 mm/s in the solution tested. These parameters were used to develop a washing device that utilized a variable flow speed dictated by changing column diameter and an upward flowing column of liquid that effectively and simultaneously suspended HDCs of various sizes in a wash solution. CONCLUSIONS This study describes a detailed method of purification of HDCs, organisms that could potentially be used for helminth therapy. It is hoped that government agencies or non-profit organizations can use such technology to conduct rigorous clinical trials, potentially leading to the production of reasonably priced therapeutics. CLINICALTRIAL Not applicable
- 23 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIsolation of Hymenolepis diminuta Cysticercoids for therapeutic use: The need for open-source methodology (Preprint)
BACKGROUND Helminth therapy holds considerable theoretical promise for clinical and public health applications. Unfortunately, clinical trials have often used helminths produced using methods that are both highly variable and insufficiently described in the literature, which may hinder reproducibility and troubleshooting. OBJECTIVE This study aimed to devise a method for purification of helminths that avoids mechanical filtration, which may damage some organisms. In particular, the goal was to devise a method to separate large quantities of cysticercoids of the cestode species Hymenolepis diminuta (HDCs), a process that has not been described previously but that would be necessary before HDCs can be used clinically. METHODS The physical size and behavior of HDCs in solution were assessed and used to create a patented washing device. RESULTS The cross-sectional area of HDCs varied over a 10-fold range, from approximately 0.06 to 0.6 mm2, dependent in large part upon the host. That cross-sectional area correlated in a linear fashion with the steady-state speed of HDCs while falling through solution, which varied over a 5-fold range, from approximately 0.4 mm/s to 2.0 mm/s in the solution tested. These parameters were used to develop a washing device that utilized a variable flow speed dictated by changing column diameter and an upward flowing column of liquid that effectively and simultaneously suspended HDCs of various sizes in a wash solution. CONCLUSIONS This study describes a detailed method of purification of HDCs, organisms that could potentially be used for helminth therapy. It is hoped that government agencies or non-profit organizations can use such technology to conduct rigorous clinical trials, potentially leading to the production of reasonably priced therapeutics. CLINICALTRIAL Not applicable